Corrigendum to “Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER)”: [Annals of Oncology 37 (2026) 1220-1229]

Annals of Oncology · Elsevier

Abstract

Publication date: Available online 20 October 2026 Source: Annals of Oncology Author(s): K. Kalinsky, W.E. Barlow, H.B. Pathak, R.V. Puri, A. Mitra, T. Home, J. Gralow, K.S. Albain, D.F. Hayes, S. Delaloge, N.U. Lin, E.A. Perez, L.J. Goldstein, S.K.L. Chia, P. Rastogi, A.F. Schott, E. Brain, J.-Y. Pierga, J.-M. Ferrero, S. Shak

Read at publisher →

Similar articles